Clinical Trials Browser

Interventional × carfilzomib × Tumor-Agnostic × Clear all

NCT02265510 2020-04-17

An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies

Phase 1/2 Terminated

83 enrolled 31 charts

Neoplasm Metastasis

NCT02257476 2017-02-07

Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms